ASEBIO to host Biospain 2010 The Spanish Bioindustry Association.
One of the most attractive aspects of BioSpain 2010 may be the chance of networking, with over 1,200 delegates from 650 companies & institutions likely to go to. Furthermore, the traders’ discussion board seeks to find new financing sources for upcoming entrepreneurial projects. 30 companies will present their business plan to an audience of investors and experts, including representatives of Merck & Co, Bay Town Capital, La Caixa, Ysios Capital Partners, GlaxoSmithKline Pharmaceuticals, Forbion Capital Partners, Suanfarma Biotech, McKinsey & Organization, and PharmaVentures..The authors recommend that objective diagnosis with an allergen-specific IgE check might yield more appropriate clinical management, reduce office appointments and improve patients’ standard of living. A specific-IgE test for allergy is an essential diagnostic tool for managed care companies and really should be a first step for effective treatment of allergic disease, stated Sheryl Szeinbach, Ph.D., Professor, Division of Pharmacy Administration and Practice, Ohio Condition University, the study’s lead author. From a useful standpoint, it could be economically wasteful and medically inappropriate for individuals without allergies to consider prescription antihistamines frequently. A total of 246 managed treatment patients who were identified as having allergies and prescribed low-sedating antihistamines consented to an allergy blood test.